---
layout: page
title: 
permalink: /project/scz-publications/
---

<div style="text-align: center;">
  <h2 style="font-weight: bold;">My Publications: Antipsychotics and Schizophrenia</h2>
</div>
<br>
#### CHRM1 and CYP1A2 gene variants effects on clozapine metabolism and working memory in schizophrenia 
<br>
<div class="paper1">
<ul style="list-style-type: none; padding-left: 0;">
  <li style="margin-bottom: 2em;">
    <strong>Islam, F.</strong>, et al. (2021).  
    <em>Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia.</em>  
    Journal of Psychopharmacology. <a href="/assets/js/islam-et-al-2020-contributions-of-cholinergic-receptor-muscarinic-1-and-cyp1a2-gene-variants-on-the-effects-of-plasma.pdf" target="_blank">[PDF]</a>
  </li>

  <li style="display: flex; gap: 2em; align-items: flex-start; margin-bottom: 3em; flex-wrap: wrap;">
    <div style="flex: 1 1 50%; text-align: center;">
      <img src="/assets/img/working_memory_clz.jpg" alt="Hypothesised model for the effect of CHRM1 rs2075748-T and rs1942499-A haplotype on the association between CLZ/NDMC ratio and working memory" style="width: 50%; height: auto; border: 1px solid #ccc; padding: 10px;">
    </div>
    <div style="flex: 1 1 50%;">
      <p style="font-size: 1em; font-style: italic; color: #555; margin: 0; line-height: 1.4em;">
        Non-carriers of the CHRM1 rs2075748-T and rs1942499-A haplotype have normal levels of transcription of the CHRM1 gene and expression of the M1R, which leads to greater sensitivity to variations in CLZ/NDMC ratio, which consequently affects working memory processes. Carriers of CHRM1 rs2075748-T and rs1942499-A haplotype have lower transcription of the CHRM1 gene and expression of M1R, leading to faster saturation of CLZ and NDMC binding sites on the M1R prior to reaching clinically detectable effects of CLZ/NDMC ratio on working memory processes. </p>
        <p style="font-size: 1em; font-style: italic; color: #555; margin: 0; line-height: 1.4em;">CHRM1: muscarinic acetylcholine receptor M1; CLZ: clozapine; M1R: M1 muscarinic acetylcholine receptor; NDMC: N-desmethylclozapine.
      </p>
    </div>
  </li>
</ul>
</div>
<br>
#### Identifying genetic variations contributing to clozapine-induced agranulocytosis
<br>
<div class="paper2">
<ul style="list-style-type: none; padding-left: 0;">
  <li style="margin-bottom: 2em;">
    <strong>Islam, F.</strong>, et al. (2022).  
    <em>Pharmacogenomics of clozapine-induced agranulocytosis: a systematic review and meta-analysis.</em>  
    The pharmacogenomics journal. <a href="/assets/js/41397_2022_Article_281.pdf" target="_blank">[PDF]</a>
  </li>

  <li style="display: flex; gap: 2em; align-items: flex-start; margin-bottom: 3em; flex-wrap: wrap;">
    <div style="flex: 1 1 50%; text-align: center;">
      <img src="/assets/img/prisma.jpg" alt="PRISMA diagram" style="width: 50%; height: auto; border: 1px solid #ccc; padding: 10px;">
    </div>
    <div style="flex: 1 1 50%;">
      <p style="font-size: 1em; font-style: italic; color: #555; margin: 0; line-height: 1.4em;"> Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart for identifying clinical studies included in this meta-analysis. </p>
    </div>
  </li>
</ul>
</div>
<br>
#### Influence of genetic factors on the efficacy and tolerability of antipsychotic treatment 
<br>
<div class="paper3">
<ul style="list-style-type: none; padding-left: 0;">
  <li style="margin-bottom: 2em;">
    <strong>Islam, F.</strong>, et al. (2021).  
    <em>Pharmacogenetics‐guided advances in antipsychotic treatment.</em>  
    Clinical Pharmacology & Therapeutics. <a href="/assets/js/Clin Pharma and Therapeutics - 2021 - Islam - Pharmacogenetics‐Guided Advances in Antipsychotic Treatment.pdf" target="_blank">[PDF]</a>
  </li>

  <li style="display: flex; gap: 2em; align-items: flex-start; margin-bottom: 3em; flex-wrap: wrap;">
    <div style="flex: 1 1 50%; text-align: center;">
      <img src="/assets/img/cpt_table2.jpg" alt="Overview of associations between gene variants and antipsychotic response or adverse effects" style="width: 50%; height: auto; border: 1px solid #ccc; padding: 10px;">
    </div>
    <div style="flex: 1 1 50%;">
      <p style="font-size: 1em; font-style: italic; color: #555; margin: 0; line-height: 1.4em;">
        PGx findings for antipsychotic response and adverse effects are summarized here. </p>
        <p style="font-size: 1em; font-style: italic; color: #555; margin: 0; line-height: 1.4em;">
    a Complete gene names can be found in Table S2 of the Supplementary Materials.
    b Association between gene variant and the phenotype reported by at least one study. 
      </p>
    </div>
  </li>
</ul>
</div>
